{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:40:46Z","timestamp":1759923646857,"version":"build-2065373602"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021708","name":"New South Wales Government","doi-asserted-by":"publisher","award":["HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629"],"award-info":[{"award-number":["HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629","HA-2024-0002629"]}],"id":[{"id":"10.13039\/501100021708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13128-3","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:58:03Z","timestamp":1759921083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation evaluation of a pharmacist prescribing service for the management of dermatological conditions: a study protocol"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-1984","authenticated-orcid":false,"given":"Noelia","family":"Amador-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9768-7838","authenticated-orcid":false,"given":"Shalom I.","family":"Benrimoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-9493","authenticated-orcid":false,"given":"Francisco","family":"Martinez-Mardones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7147-8920","authenticated-orcid":false,"given":"Simone","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-7569","authenticated-orcid":false,"given":"Joanna C.","family":"Moullin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-7624","authenticated-orcid":false,"given":"Gill","family":"Schierhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-4320","authenticated-orcid":false,"given":"Maddie","family":"Heenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7080-0108","authenticated-orcid":false,"given":"Sarah","family":"Dineen-Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"13128_CR1","unstructured":"NSWHealth. Pharmacy reform to expand community health care: New South Wales Government; 2022 [24\/01\/2024]. Available from: https:\/\/www.health.nsw.gov.au\/news\/Pages\/20221113_00.aspx."},{"issue":"739","key":"13128_CR2","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.3399\/BJGP.2023.0276","volume":"74","author":"J Voorhees","year":"2024","unstructured":"Voorhees J, Bailey S, Waterman H, Checkland K. A paradox of problems in accessing general practice: a qualitative participatory case study. Br J Gen Pract. 2024;74(739):e104\u201312.","journal-title":"Br J Gen Pract"},{"key":"13128_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/RMHP.S399045","volume":"16","author":"M Maninchedda","year":"2023","unstructured":"Maninchedda M, Proia AS, Bianco L, Aromatario M, Orsi GB, Napoli C. Main Features and Control Strategies to Reduce Overcrowding in Emergency Departments: A Systematic Review of the Literature. Risk Manag Healthc Policy. 2023;16:255\u201366.","journal-title":"Risk Manag Healthc Policy"},{"key":"13128_CR4","doi-asserted-by":"crossref","unstructured":"Dale LE, Trujillo V, Herman A, Sussman AL, Espey E, Hofler LG. Implementation of pharmacy access to hormonal contraception. J Am Pharm Assoc (2003). 2023.","DOI":"10.1016\/j.contraception.2022.09.099"},{"issue":"5","key":"13128_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.sapharm.2024.01.006","volume":"20","author":"RL Walpola","year":"2024","unstructured":"Walpola RL, Issakhany D, Gisev N, Hopkins RE. The accessibility of pharmacist prescribing and impacts on medicines access: A systematic review. Res Social Adm Pharm. 2024;20(5):475\u201386.","journal-title":"Res Social Adm Pharm"},{"key":"13128_CR6","unstructured":"APHRA. Pharmacist prescribing - Position statement - 15 October 2019: Australian Health Practitioner Regulation Agency; 2022 [04.07.2024]. Available from: https:\/\/www.pharmacyboard.gov.au\/News\/Professional-Practice-Issues\/Pharmacist-Prescribing-Position-Statement.aspx."},{"key":"13128_CR7","unstructured":"NHS. Pharmacy First Plus: National Health Service Scotland; 2024 [24.06.2024]. Available from: https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-lanarkshire\/pages\/pharmacy-services\/pharmacy-first-plus\/#:~:text=The%20Pharmacy%20First%20Plus%20Service,require%20onward%20referral%20to%20another."},{"key":"13128_CR8","unstructured":"CPhA. Pharmacists' scope of practice in Canada: Canadian Pharmacists Association; 2024 [24.06.2024]. Available from: https:\/\/www.pharmacists.ca\/advocacy\/scope-of-practice\/."},{"issue":"4","key":"13128_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4212\/cjhp.3346","volume":"76","author":"R Almawed","year":"2023","unstructured":"Almawed R, Shiu J, Bungard T, Charrois T, Gill P. Pharmacist Prescribing at Inpatient Discharge in Alberta. Can J Hosp Pharm. 2023;76(4):275\u201381.","journal-title":"Can J Hosp Pharm"},{"key":"13128_CR10","unstructured":"NHS. Independent prescribing: NHS England; 2024 [13.08.2024]. Available from: https:\/\/www.england.nhs.uk\/primary-care\/pharmacy\/pharmacy-integration-fund\/independent-prescribing\/."},{"key":"13128_CR11","doi-asserted-by":"publisher","unstructured":"Amador-Fern\u00e1ndez N, Matthey-de-l'Endroit J, Berger J. Factors influencing the implementation of a new pharmacist prescribing service in community pharmacies. Pharmacy (Basel). 2023;11(6):173. https:\/\/doi.org\/10.3390\/pharmacy11060173.","DOI":"10.3390\/pharmacy11060173"},{"key":"13128_CR12","unstructured":"DPSA. Prescribing Pharmacist: Danish Patient Safety Authority; 2023 [24\/01\/2024]. Available from: https:\/\/en.stps.dk\/health-professionals-and-authorities\/registration-of-healthcare-professionals\/prescribing-pharmacist#:~:text=Prescribing%20pharmacists%20who%20have%20received,of%20prescribing%20pharmacist%20in%20Denmark."},{"key":"13128_CR13","unstructured":"FOPPH. Simplified provision of List B medicinal products: Federal Office of Public Health; 2023 [09.08.2024]. Available from: https:\/\/www.bag.admin.ch\/bag\/en\/home\/medizin-und-forschung\/heilmittel\/abgabe-von-arzneimitteln.html."},{"key":"13128_CR14","unstructured":"QueenslandHealth. Queensland Community Pharmacy Scope of Practice Pilot: Queensland Health; 2023 [09.07.2024]. Available from: https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0029\/1166429\/Pilot_Services.pdf."},{"issue":"2","key":"13128_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.115.015464","volume":"132","author":"RT Tsuyuki","year":"2015","unstructured":"Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132(2):93\u2013100.","journal-title":"Circulation"},{"key":"13128_CR16","doi-asserted-by":"crossref","unstructured":"Rodriguez MI, Skye M, Edelman AB, Anderson L, Darney BG. Association of pharmacist prescription and 12-month contraceptive continuation rates. Am J Obstet Gynecol. 2021;225(6):647.e1-.e9.","DOI":"10.1016\/j.ajog.2021.06.089"},{"issue":"9","key":"13128_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.11124\/JBISRIR-2017-003697","volume":"16","author":"EW Poh","year":"2018","unstructured":"Poh EW, McArthur A, Stephenson M, Roughead EE. Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review. JBI Database System Rev Implement Rep. 2018;16(9):1823\u201373.","journal-title":"JBI Database System Rev Implement Rep"},{"issue":"4","key":"13128_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/YCO.0000000000000943","volume":"37","author":"A Cheetham","year":"2024","unstructured":"Cheetham A, Grist E, Nielsen S. Pharmacist-prescriber collaborative models of care for opioid use disorder: an overview of recent research. Curr Opin Psychiatry. 2024;37(4):251\u20137.","journal-title":"Curr Opin Psychiatry"},{"key":"13128_CR19","unstructured":"Azad A, Su J, Nguyen M, Ly M, Wu I, Tracy D, et al. Pharmacist furnishing of hormonal contraception in California's Central Valley. J Am Pharm Assoc (2003). 2023."},{"key":"13128_CR20","doi-asserted-by":"publisher","unstructured":"Facciolo F, Farley J. Minnesota policy on pharmacist-prescribed contraceptives: benefits, limitations, and opportunities for improvement. Innov Pharm. 2021;12(3). https:\/\/doi.org\/10.24926\/iip.v12i3.3923.","DOI":"10.24926\/iip.v12i3.3923"},{"issue":"1","key":"13128_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12961-021-00789-9","volume":"20","author":"A Kumar","year":"2022","unstructured":"Kumar A, Ray AB, Blanchard C. Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization. Health Res Policy Syst. 2022;20(1):1.","journal-title":"Health Res Policy Syst"},{"issue":"6","key":"13128_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/ijpp.12557","volume":"27","author":"M Zhou","year":"2019","unstructured":"Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract. 2019;27(6):479\u201389.","journal-title":"Int J Pharm Pract"},{"issue":"3","key":"13128_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1078155217752076","volume":"25","author":"B Au","year":"2019","unstructured":"Au B, Dersch-Mills D, Ghosh S, Jupp J, Chambers C, Cusano F, et al. Implementation of additional prescribing authorization among oncology pharmacists in Alberta. J Oncol Pharm Pract. 2019;25(3):584\u201398.","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"13128_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.sapharm.2015.08.003","volume":"12","author":"JC Moullin","year":"2016","unstructured":"Moullin JC, Sabater-Hern\u00e1ndez D, Benrimoj SI. Model for the evaluation of implementation programs and professional pharmacy services. Res Social Adm Pharm. 2016;12(3):515\u201322.","journal-title":"Res Social Adm Pharm"},{"key":"13128_CR25","unstructured":"ANZCTR. NSW Government-Sponsored Clinical Trial: Management of Urinary Tract Infections by Community Pharmacists: Australian New Zealand Clinical Trials Registry; 2023 [Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=385721&isReview=true."},{"key":"13128_CR26","unstructured":"ANZCTR. NSW Government-Sponsored Clinical Trial: Extended supply of Oral Contraceptive Pills (OCPs) by Community Pharmacists: Australian New Zealand Clinical Trials Registry; 2023 [21\/06\/2024]. Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=386648&isReview=true."},{"key":"13128_CR27","unstructured":"ANZCTR. NSW Government-Sponsored Clinical Trial: Management of Dermatology Conditions by Community Pharmacists: Australian New Zealand Clinical Trials Registry; 2024 [29\/08\/2024]. Available from: https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12624000877583."},{"key":"13128_CR28","doi-asserted-by":"publisher","first-page":"1053496","DOI":"10.3389\/frhs.2022.1053496","volume":"2","author":"GM Curran","year":"2022","unstructured":"Curran GM, Landes SJ, McBain SA, Pyne JM, Smith JD, Fernandez ME, et al. Reflections on 10 years of effectiveness-implementation hybrid studies. Front Health Serv. 2022;2:1053496.","journal-title":"Front Health Serv"},{"key":"13128_CR29","unstructured":"MedAdvisor. MedAdvisor Solutions: MedAdvisor Solutions; 2024 [24.06.2024]. Available from: https:\/\/www.medadvisorsolutions.com\/en-au\/medadvisor-for-pharmacy."},{"key":"13128_CR30","unstructured":"ACP. Skin conditions course: Australasian College of Pharmacy; 2024 [16.07.2024]. Available from: https:\/\/www.acp.edu.au\/education\/short-courses\/skin-conditions\/nsw\/."},{"key":"13128_CR31","unstructured":"PSA. Mild Plaque Psoriasis, Impetigo, Herpes Zoster and Atopic Dermatitis: Pharmaceutical Society of Australia; 2024 [16.07.2024]. Available from: https:\/\/my.psa.org.au\/s\/training-track\/a16GB000006gqEQYAY\/mild-plaque-psoriasis-impetigo-herpes-zoster-and-atopic-dermatitis."},{"key":"13128_CR32","unstructured":"TG. Therapeutic Guidelines: Therapeutic Guidelines; 2024 [16.07.2024]. Available from: https:\/\/tgldcdp.tg.org.au\/etgcomplete."},{"key":"13128_CR33","unstructured":"GIS. Competencies for Implementation Facilitators, Edition 3: Global Implementation Society Standards Committee; 2023 [09.07.2024]. Available from: https:\/\/globalimplementation.org\/gis-committees\/."},{"issue":"1","key":"13128_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-018-0842-6","volume":"14","author":"JC Moullin","year":"2019","unstructured":"Moullin JC, Dickson KS, Stadnick NA, Rabin B, Aarons GA. Systematic review of the Exploration, Preparation, Implementation, Sustainment (EPIS) framework. Implement Sci. 2019;14(1):1.","journal-title":"Implement Sci"},{"issue":"1","key":"13128_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"key":"13128_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21.","journal-title":"Implement Sci"},{"key":"13128_CR37","unstructured":"REDCap. Research Electronic Data Capture: REDCap; 2024 [24.06.2024]. Available from: https:\/\/www.project-redcap.org\/."},{"key":"13128_CR38","doi-asserted-by":"publisher","first-page":"1233597","DOI":"10.3389\/frhs.2023.1233597","volume":"3","author":"B Albers","year":"2023","unstructured":"Albers B, Rapley T, Nilsen P, Clack L. Editorial: Tailoring in implementation science. Front Health Serv. 2023;3:1233597.","journal-title":"Front Health Serv"},{"key":"13128_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2022.974095","volume":"2","author":"SM McHugh","year":"2022","unstructured":"McHugh SM, Riordan F, Curran GM, Lewis CC, Wolfenden L, Presseau J, et al. Conceptual tensions and practical trade-offs in tailoring implementation interventions. Front Health Serv. 2022;2: 974095.","journal-title":"Front Health Serv"},{"issue":"10","key":"13128_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053474","volume":"11","author":"CC Lewis","year":"2021","unstructured":"Lewis CC, Powell BJ, Brewer SK, Nguyen AM, Schriger SH, Vejnoska SF, et al. Advancing mechanisms of implementation to accelerate sustainable evidence-based practice integration: protocol for generating a research agenda. BMJ Open. 2021;11(10): e053474.","journal-title":"BMJ Open"},{"issue":"3","key":"13128_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s13142-017-0495-z","volume":"7","author":"MS Goodman","year":"2017","unstructured":"Goodman MS, Sanders Thompson VL. The science of stakeholder engagement in research: classification, implementation, and evaluation. Transl Behav Med. 2017;7(3):486\u201391.","journal-title":"Transl Behav Med"},{"key":"13128_CR42","unstructured":"TGI. Who we are: The George Institute for Global Health; 2024 [09.08.2024]. Available from: https:\/\/www.georgeinstitute.org\/who-we-are."},{"key":"13128_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1748-5908-4-29","volume":"4","author":"CR May","year":"2009","unstructured":"May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory of implementation and integration: Normalization Process Theory. Implement Sci. 2009;4:29.","journal-title":"Implement Sci"},{"issue":"2","key":"13128_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"13128_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/XEB.0000000000000447","volume":"22","author":"TA Carey","year":"2024","unstructured":"Carey TA. When is enough enough? Implementation science models and frameworks. JBI Evid Implement. 2024;22(3):239\u201341.","journal-title":"JBI Evid Implement"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13128-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13128-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13128-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:58:08Z","timestamp":1759921088000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13128-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13128"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13128-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the University of Newcastle Human Research Ethics Committee (Australia) on the 27 May 2024 (approval number H-2024\u20130002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants will be required to provide informed written consent, including consent for publication. The consent form includes the following statement \u201cFindings will be reported to the NSW Government, in peer-reviewed publications and conference presentations. Individual participants will not be identifiable in any of the publications generated. Non-identifiable data may be shared with other parties as part of a peer-review process to verify the robustness and integrity of the study, or to contribute to further research and public knowledge\u201d.All participants will be able to request a resume of study outcomes though the trial mailbox, as stated in the participant information sheet and consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1333"}}